Mildred Felder Selected Research

Mildred Felder Research Topics

Disease

19	Neoplasms (Cancer) 05/2022 - 05/2004
9	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 05/2004
4	Ovarian Epithelial Carcinoma 05/2012 - 05/2004
3	Ascites 05/2022 - 05/2004
3	Neoplasm Metastasis (Metastasis) 05/2014 - 01/2010
1	Malaria 05/2022
1	Neuroblastoma 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Hypotension (Low Blood Pressure) 01/2013
1	Hypophosphatemia 01/2013
1	Pre-Eclampsia (Preeclampsia) 07/2012
1	Endometrial Neoplasms (Endometrial Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

4	MucinsIBA 05/2014 - 01/2010
3	plumbaginIBA 11/2020 - 01/2018
2	Atovaquone (Mepron)FDA Link 05/2022 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 07/2012
2	Adenosine Triphosphatases (ATPase)IBA 11/2020 - 01/2019
2	citral (neral)IBA 01/2016 - 01/2012
2	AntigensIBA 05/2014 - 01/2011
2	Tumor Biomarkers (Tumor Markers)IBA 05/2014 - 01/2010
2	Biological ProductsIBA 05/2014 - 01/2013
2	Epithelial Cell Adhesion MoleculeIBA 01/2013 - 05/2004
2	tucotuzumab celmoleukinIBA 01/2013 - 05/2004
2	PlatinumIBA 05/2012 - 11/2008
2	ChromiumIBA 11/2008 - 05/2004
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	dinutuximabIBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	AntibodiesIBA 01/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2019
1	trans-10,cis-12-conjugated linoleic acidIBA 01/2018
1	Conjugated Linoleic AcidsIBA 01/2018
1	OligodeoxyribonucleotidesIBA 01/2017
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 12/2016
1	Epidermal Growth Factor (EGF)IBA 12/2016
1	Heparin (Liquaemin)FDA LinkGeneric 12/2016
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2016
1	Neutralizing AntibodiesIBA 12/2016
1	ErbB Receptors (EGF Receptor)IBA 12/2016
1	poly(ethylene glycol)-block-poly(epsilon-caprolactone)IBA 01/2016
1	Monoterpenes (Monoterpenoids)IBA 01/2016
1	Interleukin-2 (IL2)IBA 10/2013
1	CreatinineIBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 05/2012
1	Glycoproteins (Glycoprotein)IBA 01/2012
1	GlycoconjugatesIBA 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Polysaccharides (Glycans)IBA 01/2012
1	SteamIBA 01/2012
1	Terpenes (Terpenoids)IBA 01/2012
1	AutoantibodiesIBA 01/2012
1	CytokinesIBA 01/2012
1	ChemokinesIBA 01/2012
1	pifithrinIBA 01/2012
1	shogaolIBA 01/2012
1	gingerolIBA 01/2012
1	LigandsIBA 01/2012
1	EpitopesIBA 01/2011
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	MesothelinIBA 01/2011
1	Fas Ligand Protein (Fas Ligand)IBA 11/2008
1	Therapeutic UsesIBA 05/2004

Therapy/Procedure

4	Therapeutics 01/2019 - 05/2004
3	Immunotherapy 01/2019 - 05/2004
1	Drug Therapy (Chemotherapy) 01/2012
1	Cytoreduction Surgical Procedures 05/2004